Arthur Schwartz

SVP of Scientific Affairs at SteroTherapeutics

Arthur Schwartz is a Professor Emeritus at Microbiology and Immunology, Temple University Medical School. Dr Schwartz’s research focused on cancer chemoprevention and experimental gerontology. Has more than 40 publications on biological effects and mechanism of action of DHEA and structural analogs. Principle investigator and inventor (14 US and foreign patents) in development of non-androgenic DHEA analogs as potential human drugs. Received B.A. (Biology) from Johns Hopkins University, and Ph.D. (Microbiology and Immunology) from Harvard University.


Org chart